Nature Reviews Cancer
Does everyone develop covert cancer?
Leukaemia: A pre-leukaemic reservoir
Pancreatic Cancer: Spotlight on BRG1
Tumour microenvironment: More than just a mutagen
Bladder cancer: Seemingly similar
Epigenetics: Histone methyltransferase mutations promote leukaemia
Immunotherapy: Promising results from autologous T cell transfer
Therapy: Combination and dosing schedule are key
Signalling: Connecting metabolism and proliferation
Inflammation: Determinants of neoplastic sites
Pluripotency: Partial reprogramming induces cancer
Tumour suppressors: Hippo promotes microRNA processing
Chromatin remodelling: Looking vulnerable
Signalling: Loss of Cbl-b unleashes anti-metastatic natural killer cells
Probing a rare tumour type
Targeting Bruton's tyrosine kinase in B cell malignancies
Roles of F-box proteins in cancer
Oncogenic protein interfaces: small molecules, big challenges
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
The prenatal origins of cancer
Send Us Feedback
Are we missing a journal?
Would you like to see changes on these pages?
email us your feedback...
Event Support and Materials
Pipelines in Oncology
The Cancer Letter
Maps, Directions, and Shuttles